{"ok":true,"domain":"nejm.org","summary":{"backlinks":2314738,"ref_domains":85031,"dofollow":2180332,"nofollow":134406,"do_refdomains":77635,"dr":68,"first_seen":"2024-07-12","last_seen":"2026-09-09"},"card":{"dr":68},"found":true,"top_refdomains":[{"domain":"ox.ac.uk","links":269126,"donor_indeg":71506,"dr":66},{"domain":"blogspot.com","links":109155,"donor_indeg":868669,"dr":81},{"domain":"tylervigen.com","links":78849,"donor_indeg":1796,"dr":45},{"domain":"ipsuss.cl","links":61791,"donor_indeg":82,"dr":26},{"domain":"ac.uk","links":40646,"donor_indeg":50,"dr":23}],"top_anchors":[{"anchor":"New England Journal of Medicine","cnt":125563},{"anchor":"NEJM","cnt":112502},{"anchor":"The New England Journal of Medicine","cnt":96409},{"anchor":"Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria","cnt":87434},{"anchor":"Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal","cnt":67127}],"top_pages":[{"dst_url":"http://www.nejm.org/","backlinks":130085},{"dst_url":"https://www.nejm.org/doi/10.1056/NEJMoa1802537","backlinks":87432},{"dst_url":"https://www.nejm.org/doi/full/10.1056/NEJMe1906559","backlinks":78920},{"dst_url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2001282","backlinks":68038},{"dst_url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1905047#.Xeh2KIEGY3g.twitter","backlinks":67096}],"metrics":{"avg_ref_dr":34,"gov_edu":7,"ref_tlds":29,"distinct_anchors":50},"dr_dist":[{"bucket":"30-49","c":30},{"bucket":"0-14","c":19},{"bucket":"50-69","c":19},{"bucket":"15-29","c":26},{"bucket":"70-100","c":6}],"tld_dist":[{"tld":"com","c":42},{"tld":"org","c":17},{"tld":"edu","c":4},{"tld":"de","c":3},{"tld":"uk","c":3},{"tld":"au","c":3},{"tld":"nl","c":3},{"tld":"gov","c":2}],"history":[]}